Improvements in and relating to serotonin antagonists
申请人:ELI LILLY AND COMPANY
公开号:EP0345056A2
公开(公告)日:1989-12-06
This invention provides a method of selectively antagonizing the 5-HT₁ receptor in mammals by administering aryloxypropanolamines. Novel aryloxypropanolamines are also claimed.